Literature DB >> 17847149

Supramolecular circular helicates formed by destabilisation of supramolecular dimers.

Jacqueline Hamblin1, Floriana Tuna, Siona Bunce, Laura J Childs, Alexander Jackson, William Errington, Nathaniel W Alcock, Helene Nierengarten, Alain Van Dorsselaer, Emmanuelle Leize-Wagner, Michael J Hannon.   

Abstract

The effect of changes in the angles at the connection points of linear/circular helicates is explored as a route to control the nuclearity and architecture of metallo-supramolecular arrays. This effect is probed by changing the geometry of the metal centre used to assemble bis-pyridylimine ligands that contain a 1,3-bis(aminomethyl) benzene spacer group. Tetrahedral metal ions favour linear dimers, whereas octahedral nickel(II) predominantly gives a triangular circular helicate. Five-coordinate copper(II) falls in the middle of these extremes and results in the formation of solvent-dependent mixtures of dimer and trimer. The trinuclear, triangular, circular helicate structures, which result from coordination to copper(II) and nickel(II), are structurally characterised by X-ray crystallography and reveal that the units can aggregate into hexagonal arrays that contain anion-filled tube-like channels in the solid state.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17847149     DOI: 10.1002/chem.200700848

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  Subcomponent Self-Assembly of a Cyclic Tetranuclear FeII Helicate in a Highly Diastereoselective Self-Sorting Manner.

Authors:  Jana Anhäuser; Rakesh Puttreddy; Lukas Glanz; Andreas Schneider; Marianne Engeser; Kari Rissanen; Arne Lützen
Journal:  Chemistry       Date:  2019-08-28       Impact factor: 5.236

2.  Tetrameric cyclic double helicates as a scaffold for a molecular Solomon link.

Authors:  Jonathon E Beves; Christopher J Campbell; David A Leigh; Robin G Pritchard
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-06       Impact factor: 15.336

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.